Evaluation of PSA, free PSA, PSMA, and t
โ
Murphy, Gerald P.; Troychak, Michael J.; Cobb, Oliver E.; Bowes, Victoria A.; Ke
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 73 KB
๐ 2 views
BACKGROUND. Metastatic prostate cancer clinical evaluation is difficult. A revaluation of new prostate markers with regard to bone scans was performed. METHODS. Serial markers, including bone alkaline phosphatase (BAP), total alkaline phosphatase (TAP), prostate-specific antigen, total (PSA) and fre